{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:48:14Z","timestamp":1748983694749},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The mechanism and characteristics of early and late drug-eluting stent in-stent restenosis (DES-ISR) have not been fully clarified. Whether there are different outcomes among those patients being irrespective of their repeated treatments remain a knowledge gap.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A total of 250 patients who underwent initial stent implantation in our hospital, and then were readmitted to receive treatment for the reason of recurrent significant DES-ISR in 2016 were involved. The patients were categorized as early ISR (&lt;12 months; E-ISR; <jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a32) and late ISR (\u226512 months; L-ISR; <jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a218). Associations between patient characteristics and clinical performance, as well as clinical outcomes after a repeated percutaneous coronary intervention (PCI) were evaluated. Primary composite endpoint of major adverse cardiac events (MACEs) included cardiac death, non-fatal myocardial infarction (MI), or target lesion revascularization (TLR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Most baseline characteristics are similar in both groups, except for the period of ISR, initial pre-procedure thrombolysis in myocardial infarction, and some serum biochemical indicators. The incidence of MACE (37.5% <jats:italic toggle=\"yes\">vs<\/jats:italic>. 5.5%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.001) and TLR (37.5% <jats:italic toggle=\"yes\">vs<\/jats:italic>. 5.0%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.001) is higher in the E-ISR group. After multivariate analysis, E-ISR (odds ratio [OR], 13.267; [95% CI 4.984\u201335.311]; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.001) and left ventricular systolic dysfunction (odds ratio [OR], 6.317; [95% CI 1.145\u201334.843]; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.034) are the independent predictors for MACE among DES-ISR patients in the mid-term follow-up of 12 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Early ISR and left ventricular systolic dysfunction are associated with MACE during the mid-term follow-up period for DES-ISR patients. The results may benefit the risk stratification and secondary prevention for DES-ISR patients in clinical practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000001135","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T02:00:25Z","timestamp":1601690425000},"page":"2674-2681","source":"Crossref","is-referenced-by-count":6,"title":["Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary intervention"],"prefix":"10.1097","volume":"133","author":[{"given":"Jian-Feng","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Urumqi Friendship Hospital, Urumqi, Xinjiang 830049, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ying","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Fei","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Da","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Qing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Jian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Bing","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Bin","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Jin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run-Lin","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"R1-20230813","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4103\/0366-6999.226073","article-title":"Drug-eluting balloon versus new-generation drug-eluting stent for the treatment of in-stent restenosis: an updated systematic review and meta-analysis","volume":"131","author":"Cui","year":"2018","journal-title":"Chin Med J"},{"key":"R2-20230813","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group","volume":"331","author":"Serruys","year":"1994","journal-title":"N Engl J Med"},{"key":"R3-20230813","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"R4-20230813","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00392-006-0460-1","article-title":"Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions","volume":"96","author":"Wohrle","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"R5-20230813","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R6-20230813","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCINTERVENTIONS.110.946939","article-title":"Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry","volume":"3","author":"Stolker","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"R7-20230813","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R8-20230813","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcin.2010.09.027","article-title":"Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis","volume":"4","author":"Latib","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"R9-20230813","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcin.2013.08.011","article-title":"A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial","volume":"7","author":"Xu","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"R10-20230813","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jcin.2018.02.037","article-title":"3-Year clinical follow-up of the RIBS IV clinical trial: a prospective randomized study of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis in coronary arteries previously treated with drug-eluting stents","volume":"11","author":"Alfonso","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R11-20230813","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: the DARE trial","volume":"11","author":"Baan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R12-20230813","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"R13-20230813","first-page":"2506","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Taylor","year":"2012","journal-title":"Eur Heart J"},{"key":"R14-20230813","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ccd.23011","article-title":"Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: results from a multicenter California registry","volume":"79","author":"Yeo","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"R15-20230813","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","article-title":"A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent)","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R16-20230813","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R17-20230813","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcin.2011.07.010","article-title":"Assessing the temporal course of neointimal hyperplasia formation after different generations of drug-eluting stents","volume":"4","author":"Collet","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"R18-20230813","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1755-5922.2010.00155.x","article-title":"In-stent restenosis","volume":"29","author":"Kim","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"R19-20230813","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.addr.2006.01.015","article-title":"Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury","volume":"58","author":"Scott","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"R20-20230813","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2006.02.046","article-title":"Drug-eluting stent restenosis the pattern predicts the outcome","volume":"47","author":"Cosgrave","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R21-20230813","doi-asserted-by":"crossref","first-page":"10","DOI":"10.15420\/icr.2018.39.1","article-title":"Contemporary management of stent failure: part one","volume":"14","author":"Pal","year":"2019","journal-title":"Interv Cardiol"},{"key":"R22-20230813","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1253\/circj.CJ-16-1069","article-title":"Difference of tissue characteristics between early and late restenosis after second-generation drug-eluting stents implantation- an optical coherence tomography study","volume":"81","author":"Jinnouchi","year":"2017","journal-title":"Circ J"},{"key":"R23-20230813","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4244\/EIJ-D-16-00787","article-title":"Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study","volume":"13","author":"Song","year":"2017","journal-title":"EuroIntervention"},{"key":"R24-20230813","first-page":"61","article-title":"Optical coherence tomography in drugeluting stent restenosis: a technique in need of a strategy","volume":"65","author":"Kufner","year":"2017","journal-title":"Minerva Cardioangiol"},{"key":"R25-20230813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCA.0000000000000669","article-title":"Calcified neoatherosclerosis causing in-stent restenosis: prevalence, predictors, and implications","volume":"30","author":"Garcia-Guimaraes","year":"2019","journal-title":"Coron Artery Dis"},{"key":"R26-20230813","article-title":"Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials","author":"Koch","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R27-20230813","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI1847","article-title":"Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100","volume":"101","author":"Boren","year":"1998","journal-title":"J Clin Invest"},{"key":"R28-20230813","doi-asserted-by":"crossref","first-page":"32228","DOI":"10.1074\/jbc.M204053200","article-title":"Identification of the proteoglycan binding site in apolipoprotein B48","volume":"277","author":"Flood","year":"2002","journal-title":"J Biol Chem"},{"key":"R29-20230813","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1253\/circj.CJ-18-0619","article-title":"Different neointimal pattern in early vs. late in-stent restenosis and clinical outcomes after drug-coated balloon angioplasty- an optical coherence tomography study","volume":"82","author":"Lee","year":"2018","journal-title":"Circ J"},{"key":"R30-20230813","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/CIRCINTERVENTIONS.114.001341","article-title":"Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations","volume":"7","author":"Magalhaes","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"R31-20230813","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0735-1097(97)00334-3","article-title":"Predictive factors of restenosis after coronary stent placement","volume":"30","author":"Kastrati","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R33-20230813","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jacc.2006.08.030","article-title":"Left ventricular structure and function: basic science for cardiac imaging","volume":"48","author":"Sengupta","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R34-20230813","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10517-016-3537-5","article-title":"Features of the left ventricular functional geometry in patients with myocardial diseases with varying degrees of systolic dysfunction","volume":"162","author":"Chumarnaya","year":"2016","journal-title":"Bull Exp Biol Med"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T09:05:28Z","timestamp":1691917528000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":33,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000001135","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]}}}